#

Mucocure-AFM

Respiratory Care

Mucocure-AFM

Acebrophylline 200 mg + Fexofenadine 120 mg + Montelukast 10 mg

MUCOCURE-AFM is indicated for allergic asthma and bronchial disorders. It helps reduce airway inflammation and mucus secretion while improving breathing comfort.

The formulation supports better lung function and is effective in chronic bronchitis and allergic rhinitis, making it suitable for long-term respiratory management.

Mucocure-AFM is a triple-action formulation designed to provide effective relief from allergic asthma, bronchial inflammation, and mucus obstruction, ensuring improved respiratory comfort and airflow.

Mucocure-AFM Tablets

Key Benefits

Designed to improve respiratory comfort, reduce airway inflammation, and support healthy breathing function.

01

Improves airway patency and breathing.

02

Reduces mucus viscosity and bronchial obstruction.

03

Controls allergic inflammation in airways and nasal passages.

04

Non-sedating anti-allergic action.

05

Enhances overall respiratory function in asthma patients.

Mechanism of Action

Triple-action pharmacological formulation designed to regulate mucus, control allergic response, and improve airway function for comprehensive respiratory support.

INDICATION
Medical Use

Indications

  • Allergic asthma
  • Acute and chronic bronchitis
  • Seasonal allergic rhinitis
  • Asthma-like chronic obstructive bronchitis
  • Allergic respiratory disorders
Why Choose Mucocure-AFM?
Mucocure-AFM delivers triple-pathway respiratory protection by combining mucolytic, anti-allergic, and anti-inflammatory actions—making it a reliable choice for long-term management of allergic asthma and airway diseases.